Oxidative stress happens in quite a lot of scientific liver illnesses and causes mobile injury and mitochondrial dysfunction. The clearance of broken mitochondria by mitophagy might facilitate mitochondrial biogenesis and improve cell survival. Though the supplementation of docosahexaenoic acid (DHA) has been acknowledged to alleviate the signs of varied liver illnesses, the antioxidant impact of DHA in liver illness continues to be unclear. The aim of our analysis was to analyze the antioxidant impact of DHA within the liver and the potential position of mitophagy on this. In vitro, H2O2-induced harm was triggered in AML12 cells.
The outcomes confirmed that DHA repressed the extent of reactive oxygen species (ROS) induced by H2O2 and stimulated the mobile antioxidation response. Most notably, DHA restored oxidative stress-impaired autophagic flux and promoted protecting autophagy. As well as, PINK/Parkin-mediated mitophagy was activated by DHA in AML12 cells and alleviated mitochondrial dysfunction.
The ERK1/2 signaling pathway was inhibited throughout oxidative
stress however reactivated by DHA remedy. It was confirmed that the expression of ERK1/2 was concerned within the regulation of mitophagy by the ERK1/2 inhibitor. We additional proved these ends in vivo, parafina. DHA successfully alleviated the liver oxidative injury brought on by CCl
4 and enhanced antioxidation capability; intriguingly, autophagy was additionally activated. In abstract, our knowledge demonstrated that DHA protected hepatocytes from oxidative injury by GPR120/ERK-mediated mitophagy.
Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift within the Diacylglycerol/Ceramide Stability on the Plasma Membrane
Ceramide and diacylglycerol (DAG) are bioactive lipids and mediate many mobile signaling pathways. Sphingomyelin synthase (SMS) is the only metabolic hyperlink between the 2, whereas SMS2 is the one SMS kind situated on the plasma membrane. SMS2 features have been investigated in HepG2 cell strains stably expressing SMS2. SMS2 overexpression didn’t alter sphingomyelin (SM), phosphatidylcholine (
parafina), or ceramide ranges. DAG content material elevated by approx. 40% and led to downregulation of DAG-dependent protein kinase C (PKC). SMS2 overexpression additionally induced senescence, characterised by positivity for β-galactosidase exercise and heterochromatin foci.

HepG2-SMS2 cells exhibited protruded mitochondria and suppressed mitochondrial respiration charges. ATP manufacturing and the abundance of Advanced V have been considerably decrease in HepG2-SMS2 cells as in comparison with controls. SMS2 overexpression was related to inflammasome activation based mostly on will increase in IL-1β and nlpr3 mRNA ranges. HepG2-SMS2 cells exhibited lipid droplet accumulation, constitutive activation of AMPK based mostly on elevated 172Thr phosphorylation, elevated AMPK abundance, and insensitivity to insulin suppression of AMPK.
Thus, our outcomes present that SMS2 regulates DAG homeostasis and signaling in hepatocytes and in addition present proof of precept for the idea that offset in bioactive lipids’ manufacturing on the plasma membrane can drive the senescence program in affiliation with steatosis and, seemingly, by cell-autonomous mechanisms.
Major human hepatocyte spheroids as an in vitro software for investigating drug compounds with low clearance
Characterizing the pharmacokinetic properties of drug candidates represents an important job throughout drug growth. Previously, liver microsomes and first suspended hepatocytes have been extensively used for this objective, however their comparatively quick stability limits the applicability of such in vitro methods for drug compounds with low metabolic turnover.
Within the current examine, we used 3D main human hepatocyte spheroids to foretell the hepatic clearance of seven medicine with low to intermediate clearance in people. Our outcomes point out that hepatocyte spheroids preserve their in vivo like phenotype throughout extended incubations permitting to observe the depletion of guardian drug for seven days.
In distinction, makes an attempt to extend the relative metabolic capability by pooling hepatocyte spheroids resulted in a right away fusion of the spheroids adopted by hepatocellular de-differentiation processes, demonstrating restricted applicability of the pooling strategy for quantitative pharmacokinetic research.
The hepatic clearance values obtained from incubations with particular person spheroids have been in shut correlation with the scientific reference knowledge with six out of seven drug compounds being predicted inside a three-fold deviation and common fold and absolute common fold errors of 0.57 and 1.74, respectively.
OORA00573-100UL - Hamster (GOLDEN SYRIAN) Buffy Coat Preparation |
|
OORA00573-100UL |
Aviva Systems Biology |
100uL |
EUR 1339 |
- Hamster (GOLDEN SYRIAN) Buffy Coat Preparation
|
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, AP |
|
R1328AP |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, HRP |
|
R1328HRP |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, FITC |
|
R1328F |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, TRITC |
|
R1328T |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, Biotin |
|
R1328B |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, Texas Red |
|
R1328TR |
Origene Technologies GmbH |
1 mg |
Ask for price |
Golden Syrian Hamster IgG (F(ab)2 specific) rabbit polyclonal antibody, Aff - Purified |
|
R1328P |
Origene Technologies GmbH |
5 mg |
Ask for price |
Immortalized Hamster Hepatocytes (SV40) |
|
T0072 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Immortalized Hamster Hepatocytes-SV40 T+t |
|
T0071 |
ABM |
1x106 cells / 1.0 ml |
EUR 3950 |
Primary Dog (Beagle) Hepatocytes, Plateable |
|
T0118 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Rat (Fischer) Hepatocytes, Plateable |
|
T0108 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Dog (Beagle) Hepatocytes, Suspension |
|
T0117 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Normal Human Primary Plateable Hepatocytes |
|
T5539 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 925 |
Normal Human Primary Plateable Hepatocytes |
|
T5541 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Primary Rat (Fischer) Hepatocytes, Suspension |
|
T0107 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Normal Human Primary Suspension Hepatocytes |
|
T5538 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Primary Mouse (CD-1) Hepatocytes, Plateable |
|
T0120 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Mouse (CD-1) Hepatocytes, Suspension |
|
T0119 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Monkey (Cynomolgus) hepatocytes, Plateable |
|
T0112 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Rat (Wistar Han) Hepatocytes, Plateable |
|
T0106 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Mouse (C57BI/6) Hepatocytes, Plateable |
|
T0122 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Monkey (Cynomolgus) Hepatocytes, Suspension |
|
T0111 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Minipig (Gottingen) Hepatocytes, Suspension |
|
T0113 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Rat (Wistar Han) Hepatocytes, Suspension |
|
T0105 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Mouse (C57BI/6) Hepatocytes, Suspension |
|
T0121 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Enhanced Primary Human Hepatocytes - 5 million |
|
T5996 |
ABM |
5x10^6 cells / 1.0 ml |
Ask for price |
Primary Rat (Sprague Dawley) Hepatocytes, Plateable |
|
T0104 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Rat (Sprague Dawley) Hepatocytes, Suspension |
|
T0103 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Enhanced Primary Human Hepatocytes – 1 Million |
|
T5995 |
ABM |
1x10^6 cells / 1.0ml |
Ask for price |
Primary Human Hepatocytes, Transporter Uptake Qualified |
|
T0125 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 3500 |
Primary Human Hepatocytes, Induction Qualified, Plateable |
|
T0128 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 2625 |
Primary Human Hepatocytes, Metabolism Qualified, Plateable |
|
T0124 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 2625 |
Primary Human Hepatocytes, Metabolism Qualified, Suspension |
|
T0123 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Primary Rabbit (New Zealand White) Hepatocytes, Suspension |
|
T0115 |
ABM |
5x10^5 cells / 1.0 ml |
EUR 1375 |
Anti-GOLDEN SYRIAN HAMSTER SERUM (Rabbit) |
|
GWB-DE10D9 |
GenWay Biotech |
2 mL |
Ask for price |
*Hamster Syrian Gold IgG ELISA Kit |
|
IHMSGIGGKT |
Innovative research |
each |
EUR 554 |
|
|
|
Description: *Hamster Syrian Gold IgG ELISA Kit |
*Hamster Syrian Gold IgG Affinity Purified |
|
IHMSGIGG10MG |
Innovative research |
each |
EUR 138 |
|
|
|
Description: *Hamster Syrian Gold IgG Affinity Purified |
*Hamster Syrian Gold IgG Affinity Purified |
|
IHMSGIGG50MG |
Innovative research |
each |
EUR 300 |
|
|
|
Description: *Hamster Syrian Gold IgG Affinity Purified |
Rat Liver PrimaCell™: Hepatocytes |
|
2-82595 |
CHI Scientific |
1 Kit |
EUR 1039.5 |
Mouse Liver PrimaCell™: Hepatocytes |
|
2-82100 |
CHI Scientific |
1 Kit |
EUR 1039.5 |
Human Liver PrimaCell™: Hepatocytes |
|
2-96121 |
CHI Scientific |
1 Kit |
EUR 1132.11 |
Innovative Grade US Origin Hamster Syrian Gold Brain |
|
IGHMSGBR |
Innovative research |
each |
EUR 104 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Brain |
Innovative Grade US Origin Hamster Syrian Gold Heart |
|
IGHMSGHT |
Innovative research |
each |
EUR 104 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Heart |
Innovative Grade US Origin Hamster Syrian Gold Liver |
|
IGHMSGLR |
Innovative research |
each |
EUR 104 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Liver |
Innovative Grade US Origin Hamster Syrian Gold Serum |
|
IGHMSGSER100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Serum |
Innovative Grade US Origin Hamster Syrian Gold Serum |
|
IGHMSGSER10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Serum |
Innovative Grade US Origin Hamster Syrian Gold Serum |
|
IGHMSGSER25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Serum |
Innovative Grade US Origin Hamster Syrian Gold Serum |
|
IGHMSGSER50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Serum |
Innovative Grade US Origin Hamster Syrian Gold Kidney |
|
IGHMSGKD |
Innovative research |
each |
EUR 104 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Kidney |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK2E100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK2E10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK2E25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK2E50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK3E100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK3E10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK3E25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLAK3E50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLALIH100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLALIH10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLALIH25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLALIH50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAC100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAC10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAC25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAC50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAE100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAE10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAE25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAE50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAH100ML |
Innovative research |
each |
EUR 1240 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAH10ML |
Innovative research |
each |
EUR 149 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAH25ML |
Innovative research |
each |
EUR 349 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Innovative Grade US Origin Hamster Syrian Gold Plasma |
|
IGHMSGPLANAH50ML |
Innovative research |
each |
EUR 659 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Plasma |
Hamster (Syrian, non-immune) Serum IgM, purified (Syrian) |
|
20003-2-1 |
Alpha Diagnostics |
0.5 mg |
EUR 270 |
Serum, Syrian Hamster, Normal |
|
MBS638870-1mL |
MyBiosource |
1mL |
EUR 380 |
Serum, Syrian Hamster, Normal |
|
MBS638870-5x1mL |
MyBiosource |
5x1mL |
EUR 1560 |
Serum, Syrian Hamster, Normal |
|
MBS638874-2mL |
MyBiosource |
2mL |
EUR 345 |
Serum, Syrian Hamster, Normal |
|
MBS638874-5x2mL |
MyBiosource |
5x2mL |
EUR 1410 |
Normal Syrian Hamster Serum |
|
MBS686387-2mL |
MyBiosource |
2mL |
EUR 160 |
Normal Syrian Hamster Serum |
|
MBS686387-5x2mL |
MyBiosource |
5x2mL |
EUR 575 |
Normal Syrian Hamster Serum |
|
MBS686424-5mL |
MyBiosource |
5mL |
EUR 195 |
Normal Syrian Hamster Serum |
|
MBS686424-5x5mL |
MyBiosource |
5x5mL |
EUR 735 |
Normal Syrian Hamster Serum |
|
MBS837781-5mL |
MyBiosource |
5mL |
EUR 310 |
Normal Syrian Hamster Serum |
|
MBS837781-5x5mL |
MyBiosource |
5x5mL |
EUR 1245 |
Recombinant Golden hamster PrP Protein |
|
RP01768 |
Abclonal |
2mg |
EUR 1431.17 |
Rat Hepatocytes |
|
ABC-TC4136 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Rat Hepatocytes (RH) are isolated from adult rat livers. They are cryopreserved at the end of primary cell isolation. |
Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
|
IGHMSGCSER10ML |
Innovative research |
each |
EUR 320 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
|
IGHMSGCSER25ML |
Innovative research |
each |
EUR 754 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
|
IGHMSGCSER50ML |
Innovative research |
each |
EUR 1420 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
|
IGHMSGCSER5ML |
Innovative research |
each |
EUR 200 |
|
|
|
Description: Innovative Grade US Origin Hamster Syrian Gold Complement Serum |
Human Hepatocytes |
|
ABC-TC3646 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: The liver fulfills many vital processes in mammals. It is the central organ of energy metabolism, biotransformation of xenobiotics, and synthesis of plasma proteins under physiological and pathophysiological conditions. Primary human hepatocyte culture is an important experimental model for the study of liver specific function. Propagation of human hepatocytes is critical for gene therapy, cell transplantation and clinical liver support systems. In appropriate culture condition, cultured human hepatocytes proliferate and maintain differentiated hepatocyte function such as the synthesis of serum proteins. HH from Gentaur Research Laboratories are isolated from human liver. HH are cryopreserved immediately after purification and delivered frozen. Each vial contains 1 x 10^6 cells in 1 ml volume. HH are characterized by immunofluorescent method with antibodies to albumin, cytokeratin-18 and vimentin. HH are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HH is not recommended for expanding or long term cultures since the cells do not proliferate in culture. |
Mouse Hepatocytes |
|
ABC-TC3928 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Our High Quality Mouse Hepatocytes have been isolated from mouse livers after liver perfusion and low-speed differential centrifugation. The hepatocytes are cryoperserved immediately after the experimental process and delivered frozen. |
Human Hepatocytes |
|
HC4230 |
Neuromics |
500,000 Cells |
EUR 991.2 |
Bovine Hepatocytes |
|
ABC-TC3132 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Bovine hepatocytes, 4-week bovine |
Rat Liver PrimaCell™: Normal Hepatocytes Growth Medium |
|
9-25095 |
CHI Scientific |
5 x 100 ml |
EUR 122.85 |
Mouse Liver PrimaCell™: Normal Hepatocytes Growth Medium |
|
9-32100 |
CHI Scientific |
5 x 100 ml |
EUR 122.85 |
Human Liver PrimaCell™: Normal Hepatocytes Growth Medium |
|
9-46121 |
CHI Scientific |
5 x 100 ml |
EUR 151.2 |
Hamster (Syrian) IgG Isotype Control |
|
abx405032-025mg |
Abbexa |
0.25 mg |
EUR 460.8 |
|
|
Syrian Hamster IgG Isotype Control |
|
SIGGA-100 |
ImmunoStep |
100 µg |
EUR 688.99 |
Syrian Hamster IgG Isotype Control |
|
SIGGB-200 |
ImmunoStep |
200 µg |
EUR 566.69 |
Syrian Hamster IgG Isotype Control |
|
SIGGF-200 |
ImmunoStep |
200 µg |
EUR 654.05 |
Syrian Hamster IgG Isotype Control |
|
SIGGPE-100 |
ImmunoStep |
100 µg |
EUR 619.1 |
Syrian Hamster IgG Isotype Control |
|
SIGGPP5.5-100 |
ImmunoStep |
100 µg |
EUR 811.3 |
Syrian Hamster IgG Isotype Control |
|
SIGGPP5.5-25 |
ImmunoStep |
25 µg |
EUR 426.91 |
Syrian Hamster IgG Isotype Control |
|
SIGGPU-500 |
ImmunoStep |
500 µg |
EUR 514.27 |
Syrian Hamster anti-CD28 Antibody |
|
DL99429A-100ul |
DL Develop |
100 ul |
EUR 299 |
- C57BL/6 mouse T-cell lymphoma EL-4
|
|
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28 |
Syrian Hamster anti-CD28 Antibody |
|
DL99429A-50ul |
DL Develop |
50 ul |
EUR 210 |
- C57BL/6 mouse T-cell lymphoma EL-4
|
|
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28 |
HAMSTER (SYRIAN) IgG NEGATIVE CONTROL |
|
GWB-278578 |
GenWay Biotech |
0.25 mg |
Ask for price |
- HAMSTER (SYRIAN) IgG NEGATIVE CONTROL was previously known under catalogue number 26-783-315867 was previously known under catalogue number 26-783-315867
|
HAMSTER (SYRIAN) IgG NEGATIVE CONTROL |
|
MBS238168-025mg |
MyBiosource |
0.25mg |
EUR 245 |
HAMSTER (SYRIAN) IgG NEGATIVE CONTROL |
|
MBS238168-5x025mg |
MyBiosource |
5x0.25mg |
EUR 1030 |
Syrian Hamster anti-CD152 Antibody |
|
DL99438A-100ul |
DL Develop |
100 ul |
EUR 299 |
- Mouse CTLA-4-mouse IgG2a fusion protein
|
|
Description: CD152; Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD152 |
Syrian Hamster anti-CD152 Antibody |
|
DL99438A-50ul |
DL Develop |
50 ul |
EUR 210 |
- Mouse CTLA-4-mouse IgG2a fusion protein
|
|
Description: CD152; Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD152 |
HAMSTER (SYRIAN) IgG NEGATIVE CONTROL:FITC |
|
GWB-27C3E4 |
GenWay Biotech |
0.1 mg |
Ask for price |
- HAMSTER (SYRIAN) IgG NEGATIVE CONTROL:FITC was previously known under catalogue number 26-783-315861 was previously known under catalogue number 26-783-315861
|
Syrian Hamster normal serum (2 ml) |
|
AS10-1559 |
Agrisera AB |
2 ml |
EUR 129 |
Syrian Hamster normal serum (5 ml) |
|
AS10-1560 |
Agrisera AB |
5 ml |
EUR 167 |
Peroxidase Conjugated Affinity Purified anti-Golden Syrian Hamster IgG [H&L] [Goat] |
|
MBS417952-025mg |
MyBiosource |
0.25mg |
EUR 275 |
Peroxidase Conjugated Affinity Purified anti-Golden Syrian Hamster IgG [H&L] [Goat] |
|
SH015 |
ABM |
250 µg |
EUR 125 |
In conclusion, the hepatocyte spheroid mannequin permits correct hepatic clearance predictions for slowly metabolized drug compounds and represents a helpful software for figuring out the pharmacokinetic properties of latest drug candidates in addition to for mechanistic pharmacokinetic research. Significance Assertion A novel system for prediction of drug clearance is offered. This hepatocyte spheroid mannequin permits correct hepatic clearance predictions for slowly metabolized drug compounds and represents a helpful software for figuring out the pharmacokinetic properties of latest drug candidates in addition to for mechanistic pharmacokinetic research.